Show simple item record

dc.contributor.authorZiedonis, Douglas
dc.contributor.authorDas, Smita
dc.contributor.authorLarkin, Celine
dc.date2022-08-11T08:09:48.000
dc.date.accessioned2022-08-23T16:44:11Z
dc.date.available2022-08-23T16:44:11Z
dc.date.issued2017-09-01
dc.date.submitted2018-02-05
dc.identifier.citation<p>Dialogues Clin Neurosci. 2017 Sep;19(3):271-280. <a href="http://www.dialogues-cns.org/contents-19-3/dialoguesclinneurosci-19-271">Link to article on publisher's website</a></p>
dc.identifier.issn1294-8322 (Linking)
dc.identifier.pmid29302224
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40451
dc.description.abstractTobacco use remains a global problem, and options for consumers have increased with the development and marketing of e-cigarettes and other new nicotine and tobacco products, such as "heat-not-burn" tobacco and dissolvable tobacco. The increased access to these new products is juxtaposed with expanding public health and clinical intervention options, including mobile technologies and social media. The persistent high rate of tobacco-use disorders among those with psychiatric disorders has gathered increased global attention, including successful approaches to individual treatment and organizational-level interventions. Best outcomes occur when medications are integrated with behavioral therapies and community-based interventions. Addressing tobacco in mental health settings requires training and technical assistance to remove old cultural barriers that restricted interventions. There is still "low-hanging fruit" to be gained in educating on the proper use of nicotine replacement medications, how smoking cessation can change blood levels of specific medications and caffeine, and how to connect with quitlines and mobile technology options. Future innovations are likely to be related to pharmacogenomics and new technologies that are human-, home-, and community-facing.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29302224&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741110/
dc.rightsCopyright : © 2017 AICH - Servier Research Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/
dc.subjectneurobiology
dc.subjectnicotine
dc.subjectpharmacotherapy
dc.subjecttobacco
dc.subjecttreatment
dc.subjectBehavior and Behavior Mechanisms
dc.subjectNeuroscience and Neurobiology
dc.subjectPsychiatry and Psychology
dc.subjectSubstance Abuse and Addiction
dc.titleTobacco use disorder and treatment: new challenges and opportunities
dc.typeJournal Article
dc.source.journaltitleDialogues in clinical neuroscience
dc.source.volume19
dc.source.issue3
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4265&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3255
dc.identifier.contextkey11481628
refterms.dateFOA2022-08-23T16:44:11Z
html.description.abstract<p>Tobacco use remains a global problem, and options for consumers have increased with the development and marketing of e-cigarettes and other new nicotine and tobacco products, such as "heat-not-burn" tobacco and dissolvable tobacco. The increased access to these new products is juxtaposed with expanding public health and clinical intervention options, including mobile technologies and social media. The persistent high rate of tobacco-use disorders among those with psychiatric disorders has gathered increased global attention, including successful approaches to individual treatment and organizational-level interventions. Best outcomes occur when medications are integrated with behavioral therapies and community-based interventions. Addressing tobacco in mental health settings requires training and technical assistance to remove old cultural barriers that restricted interventions. There is still "low-hanging fruit" to be gained in educating on the proper use of nicotine replacement medications, how smoking cessation can change blood levels of specific medications and caffeine, and how to connect with quitlines and mobile technology options. Future innovations are likely to be related to pharmacogenomics and new technologies that are human-, home-, and community-facing.</p>
dc.identifier.submissionpathoapubs/3255
dc.contributor.departmentDepartment of Emergency Medicine
dc.source.pages271-280


Files in this item

Thumbnail
Name:
DialoguesClinNeurosci_19_271.pdf
Size:
3.345Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright : © 2017 AICH - Servier Research Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as Copyright : © 2017 AICH - Servier Research Group. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.